Platelet Rich Plasma Market by Type (Pure Platelet-Rich Plasma, Leukocyte-Rich Platelet-Rich Plasma, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Platelet-Rich Fibrin), by Origin (Autologous PRP, Allogeneic PRP, and Homologous PRP), by Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others), and by End-User (Hospitals & Clinics and Research Institutions): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024

Global platelet rich plasma market expected to generate revenue of around USD 438 million by the end of 2024, growing at a CAGR of around 12.90% between 2018 and 2024. Plasma rich platelets contain a high concentration of platelets, which are suspended in plasma after centrifugation. PRP promotes the healing of soft tissues after the growth factors are released.

30-Oct-2018 | Number of pages: 110 | Report Code: ZMR-3484 | Report Format : | Status : Published

Analysis

Platelet rich plasma (PRP) is a portion of plasma derived from the patient’s blood. This portion of blood has a high concentration of platelets, which promotes the healing of ligaments, muscles, joints, and tendons. PRP generally contains different growth factors and some cytokines that are responsible for initiating the healing of injuries.

According to the statistics by ISAPS (International Society of Plastic and Aesthetic Surgeons), in 2013, about 11 million cosmetic surgeries (non-invasive) were carried out across the world. According to the statistics, in 2015, about 617 million of the global population was aged above 65 years. Aging weakens the bones, which increases the chances of orthopedic impairments. The rise in the prevalence of orthopedic impairments and an increase in the number of cosmetic surgeries are expected to fuel the development of the global platelet rich plasma market. Additionally, the rise in the awareness about PRP therapy is anticipated to further contribute to this market’s growth globally. The rising occurrences of arthritis, technological advancement in PRP products and therapy, and support by government for the use of PRP therapies are some other factors driving the expansion of the global market for platelet rich plasma.

Global Platelet Rich Plasma Market

Platelet rich plasma market is segmented on the basis of type, origin, application, and end-user. Based on the type, this market is divided into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich platelet-rich fibrin. The pure PRP segment is anticipated to dominate the market in the forecast period. By origin, the market for platelet rich plasma is segmented into autologous PRP, homologous PRP, and allogeneic PRP. In 2017, the autologous PRP segment held the largest market share. By application, the platelet rich plasma market is divided cardiac muscle injury, orthopedics, dermatology, nerve injury, and others. The orthopedics segment is anticipated to lead the market for platelet rich plasma in the upcoming years. Based on end-user, the market for platelet rich plasma is segmented into hospitals and clinics and research institutes. The hospitals and clinics segment is projected to dominate the platelet rich plasma market.

North America is anticipated to lead the market for platelet rich plasma in the upcoming years, due to the increase in the number of cosmetic surgeries, rise in the cases of rheumatology, growing awareness about PRP therapy, and rapid approval by FDA for various platelet rich plasma products. In the forecast timeframe, the Asia Pacific region is anticipated to show the highest growth due to the increase in the number of people suffering from osteoporosis. The increasing number of accidents, growing awareness about technologically advance PRP products, and rising occurrences of neurological disorders are some other factors fueling the growth of the market in the Asia Pacific region.

The main players involved in the global platelet rich plasma market are Cambryn Biologics LLC, Regen Lab SA, Nuo Therapeutics, Inc., Cesca Therapeutics, Inc., Grifols International S.A., Octapharma, EmCyte Corporation, AdiStem Ltd., ISTO Biologics, and BioLife Plasma Services. These companies focus on the development of various products for the treatment of different diseases. For instance, in 2017, Cesca Therapeutics Inc. announced an autologous PRP which is used for the treatment of chronic ulcers.


Related Reports

Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Neuromonitoring devices, Respiratory monitoring devices, Anesthesia monitor, Hemodynamic monitoring devices, Fetal and neonatal monitoring, Multiparameter monitoring devices and Others), by Type (Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, and Others), and End use (Hospitals, Ambulatory surgical centers, Homecare settings, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5368 | Report Format:

The report covers forecast and analysis for the Patient Monitoring Devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Patient Mon...Read More

COVID-19 Drug Delivery Devices Market by Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), by Route of Administration (Parenteral, Nasal, and Dermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5367 | Report Format:

The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-1...Read More

Face Shield Market by Material (Cellulose Acetate, Polycarbonate, and Others), and End-User (Oil & Gas, Construction, Healthcare, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5366 | Report Format:

The report covers forecast and analysis for the face shield market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the face shield market along w...Read More

Medical Protective Goggles Market by Type (Reusable Protective Goggles and Disposable Protective Goggles), and End-User (Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5365 | Report Format:

The report covers forecast and analysis for the medical protective goggles market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the medical pro...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.